ESK981
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ESK981, covering 2023-07-14 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter Trial of ESK981 in Patients With Select Solid Tumors [Phase 2]